Purple Biotech Ltd. (PPBT) stock

PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026Score 1/30

$1.56+0.07 (+4.70%)

Close on Nov 12, 2026Market cap $1.45MP/E 0.0Yield –

Purple Biotech gross margin

Gross margin is gross profit as a percentage of revenue.

Purple Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?